1. Home
  2. HTBK vs BCYC Comparison

HTBK vs BCYC Comparison

Compare HTBK & BCYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HTBK
  • BCYC
  • Stock Information
  • Founded
  • HTBK 1997
  • BCYC 2009
  • Country
  • HTBK United States
  • BCYC United Kingdom
  • Employees
  • HTBK N/A
  • BCYC N/A
  • Industry
  • HTBK Major Banks
  • BCYC Biotechnology: Pharmaceutical Preparations
  • Sector
  • HTBK Finance
  • BCYC Health Care
  • Exchange
  • HTBK Nasdaq
  • BCYC Nasdaq
  • Market Cap
  • HTBK 588.2M
  • BCYC 566.5M
  • IPO Year
  • HTBK 1998
  • BCYC 2019
  • Fundamental
  • Price
  • HTBK $10.40
  • BCYC $8.05
  • Analyst Decision
  • HTBK Buy
  • BCYC Buy
  • Analyst Count
  • HTBK 3
  • BCYC 10
  • Target Price
  • HTBK $11.33
  • BCYC $25.00
  • AVG Volume (30 Days)
  • HTBK 476.2K
  • BCYC 304.0K
  • Earning Date
  • HTBK 07-24-2025
  • BCYC 08-05-2025
  • Dividend Yield
  • HTBK 5.01%
  • BCYC N/A
  • EPS Growth
  • HTBK N/A
  • BCYC N/A
  • EPS
  • HTBK 0.68
  • BCYC N/A
  • Revenue
  • HTBK $174,083,000.00
  • BCYC $25,722,000.00
  • Revenue This Year
  • HTBK $7.71
  • BCYC $7.35
  • Revenue Next Year
  • HTBK $6.13
  • BCYC N/A
  • P/E Ratio
  • HTBK $15.25
  • BCYC N/A
  • Revenue Growth
  • HTBK N/A
  • BCYC N/A
  • 52 Week Low
  • HTBK $8.09
  • BCYC $6.10
  • 52 Week High
  • HTBK $11.27
  • BCYC $28.67
  • Technical
  • Relative Strength Index (RSI)
  • HTBK 66.25
  • BCYC 55.72
  • Support Level
  • HTBK $10.41
  • BCYC $7.06
  • Resistance Level
  • HTBK $10.77
  • BCYC $8.12
  • Average True Range (ATR)
  • HTBK 0.23
  • BCYC 0.40
  • MACD
  • HTBK 0.05
  • BCYC 0.12
  • Stochastic Oscillator
  • HTBK 75.00
  • BCYC 95.20

About HTBK Heritage Commerce Corp

Heritage Commerce Corp operates as a bank holding company. The company, through its subsidiary, offers commercial banking services to small and medium-sized businesses and their owners, managers, and employees. It operates through two reportable segments, namely Banking and Factoring. A majority of its revenue is generated from the Banking segment, which provides various loan products, including commercial and industrial loans, commercial real estate loans, construction loans, etc. This segment also focuses on deposit generation on relationship accounts, encompassing non-interest bearing demand, interest bearing demand, money market accounts, certificates of deposit, and savings accounts.

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.

Share on Social Networks: